ImmuSAFE Instructions

lmmuSAFE™ web applications instructions

To begin generating your report on the ImmuSAFE™ Cloud-based Analysis portal, please visit and perform the following steps:

Step 1

Download the “Data Input” and “Sample Manifest” template sheets.

Step 2

Fill in the “Data Input” sheet with the required information from the .GPR files:
1. Slide ID
2. Block Number
3. Name
4. ID/Protein
5. F635 Median
6. B635 Median
7. B635 SD

Step 3

Fill in patient specific details in the “Sample Manifest” sheet with the following information :
1. Slide ID
2. Block Number
3. Sample ID
4. Date of Birth
5. ID or MRN Number
6. Gender
7. RT-PCR status
8. Date of Sample collection
9. Date of Sample Run
10. COVID-19 Symptoms
11. Project ID
(Note: Please ensure that the Slide ID and Block Number for both sheets match)

Step 4

Upload the sheets to the ImmuSAFE™ Cloud-based Analysis portal and key in the requested details for report delivery.

Step 5

An individual report for each sample will be generated and sent to the email address provided in Step 4.

lmmuSAFE™ utilises Sengenics’ patented KREX™ protein folding technology ensuring that viral antigens are correctly folded, preserving all conformational and linear antibody binding sites. More than ten domains of SARS-CoV-2 Nucleocapsid and Spike proteins including both full-length and numerous truncated versions are used in the tests.

The biochip enables the determination of the target epitopes, titres and immunoglobulin class/sub-class (lgG, lgA, lgM; lgG1-4) of antibodies produced across all stages of COVID-19 infection, from initial exposure, disease development, post-recovery or post-vaccination. lmmuSAFE™ can also enable quantitative assessment of patient response in vaccination trials, including differentiation of whether observed antibody responses are due directly to the vaccine or to prior SARS-CoV-2 exposure.


IMMUNOME Protein Array

High-throughput autoantibody screening protein array containing 1600+ autoantigens


Contains correctly folded antigens from SARS-CoV-2 and 25 other Corona and Influenza viruses

SEROMAX Blood Collection Kit

Obviates conventional blood draw and cold chain by only requiring a pin-prick of blood

Sengenics - Functional Proteomics | Krex Technology | Protein Array Supplier

Sengenics is a functional proteomics company that leverages its patented KREX technology for production of full-length, correctly folded and functional proteins. The key application of KREX is the discovery of autoantibody biomarkers for two core medical use cases:  stratification of patients undergoing treatment with autoimmune or cancer drugs and identification of autoantibody biomarkers that may be used to diagnose cancer, autoimmune or neurodegenerative conditions. Some autoantibodies that are identified as diagnostic biomarkers may be protective and have potential in themselves as therapeutic biomolecules.

Find Us On:

© 2008 – 2021 Sengenics All rights reserved | Sengenics Corporation Pte Ltd. Registered in Singapore no. 201734100D | Sengenics UK Ltd. Registered in England and Wales No 11016361